Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review

Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal on addictions 2010-01, Vol.19 (1), p.4-16
Hauptverfasser: McCance-Katz, Elinore F., Sullivan, Lynn E., Nallani, Srikanth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 16
container_issue 1
container_start_page 4
container_title The American journal on addictions
container_volume 19
creator McCance-Katz, Elinore F.
Sullivan, Lynn E.
Nallani, Srikanth
description Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid‐addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area. (Am J Addict 2009;19:4–16)
doi_str_mv 10.1111/j.1521-0391.2009.00005.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3334287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57333073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5655-51d0061a6f84f574e1c594bfd1cfca24b2762f2046cd6dcbc9b0bb1876bdab2d3</originalsourceid><addsrcrecordid>eNqNUd1u0zAUthCIjcIrIF9xtQTbiZ0EJKTSsVI0KEMgLi3HdlqXxA52urUvwTPjtKOCO86Fbfn7OefoAwBilOJYLzcppgQnKKtwShCqUhSLprsH4PwEPIxvRGmC8oqdgSchbEZSWbHH4IwgnBGMi3Pw69JvV3BhB-2FHIyzAboGzlpjjRQtXHS984OwUkPRObuCw1rDZW-cUeECftTDWihnI2gVfLvtvbbO92tj9cXhaxnpHl55_XOr7dDu4Wevg_Sm1iqKVWxxaPkKTuEXfWv03VPwqBFt0M_u7wn4dvXu6-x9cr2cL2bT60RSFneiWCHEsGBNmTe0yDWWtMrrRmHZSEHymhSMNATlTCqmZC2rGtU1LgtWK1ETlU3Am6Nvv607rWSczouW9950wu-5E4b_i1iz5it3y7Msy0lZRIMX9wbexeXCwDsTpG5bYbXbBk6LyETxmIDySJTeheB1c2qCER_D5Bs-ZsbHzPgYJj-EyXdR-vzvIU_CP-lFwusj4c60ev_fxnz6YXpJozo5qk0Y9O6kFv4HZ0VWUP7905xXdD7Pb24wp9lvNam_yw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57333073</pqid></control><display><type>article</type><title>Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>McCance-Katz, Elinore F. ; Sullivan, Lynn E. ; Nallani, Srikanth</creator><creatorcontrib>McCance-Katz, Elinore F. ; Sullivan, Lynn E. ; Nallani, Srikanth</creatorcontrib><description>Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid‐addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area. (Am J Addict 2009;19:4–16)</description><identifier>ISSN: 1055-0496</identifier><identifier>EISSN: 1521-0391</identifier><identifier>DOI: 10.1111/j.1521-0391.2009.00005.x</identifier><identifier>PMID: 20132117</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Addicts ; Buprenorphine ; Buprenorphine - adverse effects ; Buprenorphine - pharmacokinetics ; Cytochrome P-450 CYP2D6 Inhibitors ; Drug Interactions ; Humans ; Illicit Drugs - adverse effects ; Methadone ; Methadone - adverse effects ; Methadone - pharmacokinetics ; Methadone - pharmacology ; Morbidity-Mortality ; Opioid-Related Disorders - drug therapy ; Opioids ; Prescribed ; Prescription Drugs - adverse effects ; Substance-Related Disorders - complications ; Substance-Related Disorders - drug therapy</subject><ispartof>The American journal on addictions, 2010-01, Vol.19 (1), p.4-16</ispartof><rights>American Academy of Addiction Psychiatry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5655-51d0061a6f84f574e1c594bfd1cfca24b2762f2046cd6dcbc9b0bb1876bdab2d3</citedby><cites>FETCH-LOGICAL-c5655-51d0061a6f84f574e1c594bfd1cfca24b2762f2046cd6dcbc9b0bb1876bdab2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1521-0391.2009.00005.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1521-0391.2009.00005.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,30977,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20132117$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McCance-Katz, Elinore F.</creatorcontrib><creatorcontrib>Sullivan, Lynn E.</creatorcontrib><creatorcontrib>Nallani, Srikanth</creatorcontrib><title>Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review</title><title>The American journal on addictions</title><addtitle>Am J Addict</addtitle><description>Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid‐addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area. (Am J Addict 2009;19:4–16)</description><subject>Addicts</subject><subject>Buprenorphine</subject><subject>Buprenorphine - adverse effects</subject><subject>Buprenorphine - pharmacokinetics</subject><subject>Cytochrome P-450 CYP2D6 Inhibitors</subject><subject>Drug Interactions</subject><subject>Humans</subject><subject>Illicit Drugs - adverse effects</subject><subject>Methadone</subject><subject>Methadone - adverse effects</subject><subject>Methadone - pharmacokinetics</subject><subject>Methadone - pharmacology</subject><subject>Morbidity-Mortality</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Opioids</subject><subject>Prescribed</subject><subject>Prescription Drugs - adverse effects</subject><subject>Substance-Related Disorders - complications</subject><subject>Substance-Related Disorders - drug therapy</subject><issn>1055-0496</issn><issn>1521-0391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNUd1u0zAUthCIjcIrIF9xtQTbiZ0EJKTSsVI0KEMgLi3HdlqXxA52urUvwTPjtKOCO86Fbfn7OefoAwBilOJYLzcppgQnKKtwShCqUhSLprsH4PwEPIxvRGmC8oqdgSchbEZSWbHH4IwgnBGMi3Pw69JvV3BhB-2FHIyzAboGzlpjjRQtXHS984OwUkPRObuCw1rDZW-cUeECftTDWihnI2gVfLvtvbbO92tj9cXhaxnpHl55_XOr7dDu4Wevg_Sm1iqKVWxxaPkKTuEXfWv03VPwqBFt0M_u7wn4dvXu6-x9cr2cL2bT60RSFneiWCHEsGBNmTe0yDWWtMrrRmHZSEHymhSMNATlTCqmZC2rGtU1LgtWK1ETlU3Am6Nvv607rWSczouW9950wu-5E4b_i1iz5it3y7Msy0lZRIMX9wbexeXCwDsTpG5bYbXbBk6LyETxmIDySJTeheB1c2qCER_D5Bs-ZsbHzPgYJj-EyXdR-vzvIU_CP-lFwusj4c60ev_fxnz6YXpJozo5qk0Y9O6kFv4HZ0VWUP7905xXdD7Pb24wp9lvNam_yw</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>McCance-Katz, Elinore F.</creator><creator>Sullivan, Lynn E.</creator><creator>Nallani, Srikanth</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>5PM</scope></search><sort><creationdate>201001</creationdate><title>Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review</title><author>McCance-Katz, Elinore F. ; Sullivan, Lynn E. ; Nallani, Srikanth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5655-51d0061a6f84f574e1c594bfd1cfca24b2762f2046cd6dcbc9b0bb1876bdab2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Addicts</topic><topic>Buprenorphine</topic><topic>Buprenorphine - adverse effects</topic><topic>Buprenorphine - pharmacokinetics</topic><topic>Cytochrome P-450 CYP2D6 Inhibitors</topic><topic>Drug Interactions</topic><topic>Humans</topic><topic>Illicit Drugs - adverse effects</topic><topic>Methadone</topic><topic>Methadone - adverse effects</topic><topic>Methadone - pharmacokinetics</topic><topic>Methadone - pharmacology</topic><topic>Morbidity-Mortality</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Opioids</topic><topic>Prescribed</topic><topic>Prescription Drugs - adverse effects</topic><topic>Substance-Related Disorders - complications</topic><topic>Substance-Related Disorders - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McCance-Katz, Elinore F.</creatorcontrib><creatorcontrib>Sullivan, Lynn E.</creatorcontrib><creatorcontrib>Nallani, Srikanth</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal on addictions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McCance-Katz, Elinore F.</au><au>Sullivan, Lynn E.</au><au>Nallani, Srikanth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review</atitle><jtitle>The American journal on addictions</jtitle><addtitle>Am J Addict</addtitle><date>2010-01</date><risdate>2010</risdate><volume>19</volume><issue>1</issue><spage>4</spage><epage>16</epage><pages>4-16</pages><issn>1055-0496</issn><eissn>1521-0391</eissn><abstract>Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid‐addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area. (Am J Addict 2009;19:4–16)</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20132117</pmid><doi>10.1111/j.1521-0391.2009.00005.x</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1055-0496
ispartof The American journal on addictions, 2010-01, Vol.19 (1), p.4-16
issn 1055-0496
1521-0391
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3334287
source Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Addicts
Buprenorphine
Buprenorphine - adverse effects
Buprenorphine - pharmacokinetics
Cytochrome P-450 CYP2D6 Inhibitors
Drug Interactions
Humans
Illicit Drugs - adverse effects
Methadone
Methadone - adverse effects
Methadone - pharmacokinetics
Methadone - pharmacology
Morbidity-Mortality
Opioid-Related Disorders - drug therapy
Opioids
Prescribed
Prescription Drugs - adverse effects
Substance-Related Disorders - complications
Substance-Related Disorders - drug therapy
title Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T09%3A51%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20Interactions%20of%20Clinical%20Importance%20among%20the%20Opioids,%20Methadone%20and%20Buprenorphine,%20and%20Other%20Frequently%20Prescribed%20Medications:%20A%20Review&rft.jtitle=The%20American%20journal%20on%20addictions&rft.au=McCance-Katz,%20Elinore%20F.&rft.date=2010-01&rft.volume=19&rft.issue=1&rft.spage=4&rft.epage=16&rft.pages=4-16&rft.issn=1055-0496&rft.eissn=1521-0391&rft_id=info:doi/10.1111/j.1521-0391.2009.00005.x&rft_dat=%3Cproquest_pubme%3E57333073%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=57333073&rft_id=info:pmid/20132117&rfr_iscdi=true